DISCO Pharmaceuticals Funding: $38M Raised, Seed (2025)
DISCO Pharmaceuticals is based in Boston. It has raised $38M in total funding. Latest round: Seed.
DISCO Pharmaceuticals funding overview
DISCO Pharmaceuticals is based in Boston. DISCO Pharmaceuticals has raised $38M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in December 2025. The round record for DISCO Pharmaceuticals runs through 2025; nothing later has been disclosed. Investors on record include Ackermans & van Haaren, NRW.Bank, Sofinnova Partners, AbbVie Ventures, M Ventures, Panakes Partners. 6 distinct backers are named across the disclosed rounds.
DISCO Pharmaceuticals at a glance
Total raised
$38M
Latest round
Seed
Latest round date
December 2025
Headquarters
Boston
Notable investors
Ackermans & van Haaren, NRW.Bank, Sofinnova Partners, AbbVie Ventures, M Ventures, Panakes Partners
Frequently asked about DISCO Pharmaceuticals funding
How much has DISCO Pharmaceuticals raised?
DISCO Pharmaceuticals has raised $38M in total disclosed funding across the rounds on record.
Who has invested in DISCO Pharmaceuticals?
Ackermans & van Haaren, NRW.Bank, Sofinnova Partners, AbbVie Ventures, M Ventures, Panakes Partners are named among the investors backing DISCO Pharmaceuticals.
What was the latest DISCO Pharmaceuticals funding round?
The most recent disclosed round is a Seed, announced in December 2025.
Where is DISCO Pharmaceuticals based?
DISCO Pharmaceuticals is based in Boston.
When did DISCO Pharmaceuticals last raise?
The last disclosed DISCO Pharmaceuticals round closed in December 2025 at Seed.
DISCO Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.
